Please provide your email address to receive an email when new articles are posted on . Fewer than half of veterans, most of whom were not on lipid-lowering therapy before an event, received ...
The value of perioperative β-blocker therapy and preoperative prophylactic coronary revascularization has been widely debated over the years. Garcia and McFalls state in their editorial paper that it ...
PARIS, France—There is no excess risk of death from noncardiac causes in patients with chronic coronary syndromes (CCS) treated with revascularization and medical therapy when compared with those who ...
Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk. (HealthDay News) — For patients ...
The Arterial Revascularization Therapy Study (ARTS I) [1] was the largest randomized, controlled trial that compared percutaneous coronary intervention (PCI) with stents to bypass surgery (CABG) in ...
Phoenix, AZ (May 19, 2023)- New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent ...
The SENIOR-RITA data suggest medical therapy is a better option for older, severely frail NSTEMI patients, says Vinay ...
An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...
Please provide your email address to receive an email when new articles are posted on . Ticagrelor monotherapy after 3-month DAPT was not associated with greater risk for repeat revascularization or ...
Cagent Vascular, a leader in innovative endovascular technologies, today announced the publication of a peer-reviewed study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results